Diabetes trends in Japan

Diabetes/Metabolism Research and Reviews

Volumn 18, Issue SUPPL. 3, 2002, Pages

  Kawamori, Ryuzo ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Beta 3 adrenergic receptor; Diabetes epidemiology; Insulin resistance; Japan; Peroxisome proliferator activated receptor ; Westernization

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; CALPAIN; CALPAIN 10; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG;

ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DIETARY INTAKE; FAT INTAKE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE METABOLISM; HEREDITY; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; JAPAN; LIFESTYLE; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SITTING;

DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; DIET; GENOTYPE; HUMANS; HYPERGLYCEMIA; JAPAN; LIFE STYLE; PREVALENCE;

EID: 0036711306     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.296     Document Type: Article

References (19)

1. Seidell JC. Obesity, insulin resistance and diabetes: a worldwide epidemic. Br J Nutr 2000; 83 (Suppl. 1): S5-S8.
2. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997; 14 (Suppl. 5): S1-S85.
3. Data from the Annual Japanese Health and Welfare Statistics (monograph). Health and Statistics Association, Ministry of Health, 1997; Tokyo: Japan.
4. Yamada M, Wong FL, Kodama K, Sasaki H, Shimaoka K, Yamakido M. Longitudinal trends in total serum cholesterol levels in a Japanese cohort, 1958-1986. J Clin Epidemiol 1997; 50: 425-434.
5. Sugimori H, Miyakawa M, Yoshida K, et al. Health risk assessment for diabetes mellitus based on longitudinal analysis of MHTS database. J Med Syst 1998; 22: 27-32.
6. Torra IP, Chinetti G, Duval C, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors: from transcriptional control to clinical practice. Curr Opin Lipidol 2001; 12: 245-254.
7. Kersten S, Desvergne B, Wahli W. Roles of PPARs in health and disease. Nature 2000; 405: 421-424.
8. Hara K, Okada T, Tobe K, et al. The Pro 12Ala polymorphism in PPARγ2 may confer resistance to type 2 diabetes. Biochem Biophys Res Commun 2000; 271: 212-216.
9. Mori Y, Kim-Motoyama H, Katakura T, et al. Effect of the Pro 12Ala variant of the human peroxisome proliferator-activated receptor gamma 2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men. Biochem Biophys Res Commun 1998; 251: 195-198.
10. Garcia-Rubi E, Calles-Escandon J. Insulin resistance and type 2 diabetes mellitus: its relationship with the beta 3-adrenergic receptor. Arch Med Res 1999; 30: 459-464.
11. Kadowaki H, Tasuda K, Iwamoto K, et al. A mutation in the beta 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun 1995; 215: 555-560.
12. Baier LJ, Permana PA, Yang X, et al. A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest 2000; 106: R69-R73.
13. Tanaka Y, Atsumi Y, Asahina T, et al. Usefulness of revised fasting plasma glucose criterion and characteristics of the insulin response to an oral glucose load in newly diagnosed Japanese diabetic subjects. Diabetes Care 1998; 21: 1133-1137.
14. Tanaka Y, Atsumi Y, Matsuoka K, Onuma T, Kawamori R. Interesting insulin response to oral glucose load in young Japanese subjects with impaired glucose tolerance. Diabetes Care 2000; 23: 710-712.
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
16. Fujimoto WY. The importance of insulin resistance in the pathogenesis of type 2 diabetes mellitus. Am J Med 2000; 108 (Suppl. 6a): 9S-14S.
17. Laakso M, Lehto S. Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance. Atherosclerosis 1998; 137 (Suppl.): S65-S73.
18. McLaughlin T, Reaven G. Insulin resistance and hypertension: patients in double jeopardy for cardiovascular disease. Geriatrics 2000; 55: 28-32, 35.
19. Fujishima M, Kiyohara Y, Kato I, et al. Diabetes and cardiovascular disease in a prospective population survey in Japan. The Hisayama Study. Diabetes 1996; 45 (Suppl. 3): S14-S16.